The Cigna Group (BVMF:C1IC34)
Brazil · Delayed Price · Currency is BRL 370.28
+19.28 (5.49%)
At close: Feb 5, 2026
The Cigna Group Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 273,854 | 246,148 | 194,099 | 179,363 | 172,520 |
Other Revenue | 1,046 | 973 | 1,166 | 1,155 | 1,549 |
| 274,900 | 247,121 | 195,265 | 180,518 | 174,069 | |
Revenue Growth (YoY) | 11.24% | 26.56% | 8.17% | 3.71% | 8.52% |
Cost of Revenue | 249,340 | 221,157 | 170,088 | 157,018 | 151,118 |
Gross Profit | 25,560 | 25,964 | 25,177 | 23,500 | 22,951 |
Selling, General & Admin | 13,691 | 14,569 | 14,324 | 13,045 | 12,791 |
Amortization of Goodwill & Intangibles | 1,743 | 1,703 | 1,819 | 1,876 | 1,998 |
Operating Expenses | 15,434 | 16,272 | 16,143 | 14,921 | 14,789 |
Operating Income | 10,126 | 9,692 | 9,034 | 8,579 | 8,162 |
Interest Expense | -1,408 | -1,435 | -1,446 | -1,228 | -1,119 |
EBT Excluding Unusual Items | 8,718 | 8,257 | 7,588 | 7,351 | 7,043 |
Merger & Restructuring Charges | -1,076 | -275 | -297 | -157 | -337 |
Gain (Loss) on Sale of Investments | -24 | -2,737 | -78 | -487 | 198 |
Gain (Loss) on Sale of Assets | 13 | 24 | -1,499 | 1,662 | - |
Legal Settlements | - | - | -201 | 28 | 27 |
Other Unusual Items | 150 | - | - | - | -141 |
Pretax Income | 7,781 | 5,269 | 5,513 | 8,397 | 6,790 |
Income Tax Expense | 1,493 | 1,491 | 141 | 1,615 | 1,370 |
Earnings From Continuing Operations | 6,288 | 3,778 | 5,372 | 6,782 | 5,420 |
Minority Interest in Earnings | -331 | -344 | -208 | -78 | -50 |
Net Income | 5,957 | 3,434 | 5,164 | 6,704 | 5,370 |
Net Income to Common | 5,957 | 3,434 | 5,164 | 6,704 | 5,370 |
Net Income Growth | 73.47% | -33.50% | -22.97% | 24.84% | -36.51% |
Shares Outstanding (Basic) | 269 | 280 | 294 | 310 | 338 |
Shares Outstanding (Diluted) | 269 | 283 | 297 | 313 | 341 |
Shares Change (YoY) | -5.17% | -4.60% | -5.17% | -8.18% | -7.44% |
EPS (Basic) | 22.18 | 12.25 | 17.57 | 21.66 | 15.89 |
EPS (Diluted) | 22.18 | 12.12 | 17.39 | 21.41 | 15.75 |
EPS Growth | 83.00% | -30.30% | -18.78% | 35.94% | -31.40% |
Free Cash Flow | 9,601 | 8,957 | 10,240 | 7,361 | 6,037 |
Free Cash Flow Per Share | 35.75 | 31.63 | 34.49 | 23.51 | 17.71 |
Dividend Per Share | 6.040 | 5.600 | 4.920 | 4.480 | 4.000 |
Dividend Growth | 7.86% | 13.82% | 9.82% | 12.00% | 9900.00% |
Gross Margin | 9.30% | 10.51% | 12.89% | 13.02% | 13.18% |
Operating Margin | 3.68% | 3.92% | 4.63% | 4.75% | 4.69% |
Profit Margin | 2.17% | 1.39% | 2.65% | 3.71% | 3.08% |
Free Cash Flow Margin | 3.49% | 3.62% | 5.24% | 4.08% | 3.47% |
EBITDA | 12,901 | 11,446 | 10,846 | 10,436 | 9,963 |
EBITDA Margin | 4.69% | 4.63% | 5.56% | 5.78% | 5.72% |
D&A For EBITDA | 2,775 | 1,754 | 1,812 | 1,857 | 1,801 |
EBIT | 10,126 | 9,692 | 9,034 | 8,579 | 8,162 |
EBIT Margin | 3.68% | 3.92% | 4.63% | 4.75% | 4.69% |
Effective Tax Rate | 19.19% | 28.30% | 2.56% | 19.23% | 20.18% |
Revenue as Reported | 274,900 | 247,121 | 195,265 | 180,518 | 174,069 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.